White Paper

White Paper – Proposed QMSR Expert Analysis (Part 1)

Medicept
by Medicept
1 min read
March 4, 2022

On Feb. 23, 2022, the U.S. FDA published the Draft Proposed Rulemaking for the new “Quality Management System Regulation.” It’s imperative that the entire industry thoroughly understand the new proposal and any nuances. This White Paper is Part 1 of a series of technical analyses to help inform any interested parties.

 
Previous story
← FDA Proposed Quality Management System Regulation (QMSR): Expert Analysis – Part 1: Understanding Definitions White Paper Download
Next story
White Paper – Proposed QMSR Expert Analysis (Part 2) →
White Paper – Proposed QMSR Expert Analysis (Part 2)
FDA building
White Paper

White Paper – Proposed QMSR Expert Analysis (Part 2)

May 17, 2022 1 min read
White Paper – FDA Guidance Documents for De Novo Classification Requests
road to successful De Novo Classification Requests
White Paper

White Paper – FDA Guidance Documents for De Novo Classification Requests

June 29, 2022 1 min read
FDA Proposed Quality Management System Regulation (QMSR): Expert Analysis – Part 2: Understanding Proposed 21 CFR 820.35 – Records White Paper Download
FDA proposed quality management system regulation (QMSR) expert analysis part 2
White Paper

FDA Proposed Quality Management System Regulation (QMSR): Expert Analysis – Part 2: Understanding Proposed 21 CFR 820.35 – Records White Paper Download

May 17, 2022 1 min read

Patients Are Waiting.

Every submission, study, inspection, and commercialization decision moves a patient closer to the technology they're waiting for. Partner with Medicept to navigate every milestone with clarity, continuity, and confidence.

Talk to an Expert